Table 2.
Criterion | A | Intra-group comparison before and after treatment (P values)* |
B | Intra-group comparison before and after treatment (P values)* |
||||||
---|---|---|---|---|---|---|---|---|---|---|
Before treatment | After treatment | Before treatment | After treatment | |||||||
N | % | N | % | N | % | N | % | |||
Abundant vaginal discharge | 35 | 100 | 8 | 22.9 | P < 0.001 | 35 | 100 | 10 | 28.6 | P < 0.001 |
Malodor | 35 | 100 | 4 | 11.4 | P < 0.001 | 35 | 100 | 2 | 5.7 | P < 0.001 |
Itching | 14 | 40 | 3 | 8.6 | P = 0.001 | 13 | 37.1 | 5 | 14.3 | P = 0.057 |
Dyspareunia | 12 | 34.3 | 4 | 11.4 | P = 0.021 | 9 | 25.7 | 1 | 2.9 | P = 0.008 |
Abdominal pain | 11 | 31.4 | 3 | 8.6 | P = 0.008 | 17 | 48.6 | 5 | 14.3 | P = 0.004 |
Group (n) | 35 | 35 | 35 | 35 | ||||||
Comparison of the two groups after treatment P > 0.05** |
A sucrose gel, B metronidazole gel, N % number and percentage of patients within each endpoint for each treatment group, Group (n) the number of patients in each group
*Derived from the McNemar test
**Derived from the chi-square test